From: Chemo-informatics activity prediction, ligand based drug design, Molecular docking and pharmacokinetics studies of some series of 4, 6-diaryl-2-pyrimidinamine derivatives as anti-cancer agents
S/NO
MW
HBD
HBA
WlogP
Lipinski violation
Bio availability score
Drug likeness
N1
582.69
3
7
4.65
1
0.55
YES
N2
581.70
5.71
N3
N4
569.65
8
4.59
N5
634.52
5.05